Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
MIAMI--(BUSINESS WIRE)--Aug. 1, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology, today announced plans to participate in two upcoming investor conferences.
邁阿密--（商業線）--2024年8月1日--pulse biosciences公司（Nasdaq: PLSE）（“公司”或“pulse biosciences”）利用其新穎專有的納秒脈衝場消融（nsPFA）技術，宣佈計劃參加兩個即將舉行的投資者會議。
- 9th Annual Needham MedTech & Diagnostics 1x1 Conference, virtual participation. Management will host 1x1 meetings on Tuesday, August 13, 2024. There will be no formal presentation.
- Canaccord Genuity Annual Growth Conference in Boston, Massachusetts. Management is scheduled to present on Wednesday, August 14, 2024, at 8:00am ET. A live and recorded webcast of the event will be available at .
- 第九屆Needham MedTech&Diagnostics 1x1會議，虛擬參與。公司管理層將於2024年8月13日星期二舉行1x1會議，沒有正式演講。
- Canaccord Genuity年度增長會議將在馬薩諸塞州波士頓舉行。管理層計劃於2024年8月14日星期三上午8:00 Et進行演講。現場和錄播網絡直播將在網站上提供。
About Pulse Biosciences
關於Pulse Biosciences
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company's proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Pulse Biosciences is now headquartered in Miami, Florida and maintains its office in Hayward, California.
pulse biosciences是一家新型生物電醫藥公司，致力於健康創新，具有改善患者生活質量的潛力。該公司專有的CellFX nsPFA技術將納秒脈衝電能傳遞到非熱清晰細胞中，同時保護相鄰的非細胞組織。該公司正積極開發其CellFX nsPFA技術，用於治療心房顫動和其他少數市場，在這些市場上，它可能對患者和醫療提供者的醫療保健產生深遠的積極影響。pulse biosciences現總部設在佛羅里達州的邁阿密，並在加利福尼亞州的海沃德維持其辦公室。
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.
Pulse Biosciences，CellFX，Nano-Pulse Stimulation，NPS，nsPFA，CellFX nsPFA以及這些圖標都是Pulse Biosciences，Inc.在美國和其他國家/地區的商標和/或註冊商標。
View source version on businesswire.com:
請查看商業線(businesswire.com)的源版本。
Investors:
Pulse Biosciences, Inc.
Burke T. Barrett, President and CEO
IR@pulsebiosciences.com
投資者：
脈衝生物科學公司
巴克·T·巴雷特總裁兼首席執行官
IR@pulsebiosciences.com
Or
或者
Gilmartin Group
Philip Trip Taylor
415.937.5406
philip@gilmartinir.com
吉爾馬汀集團
菲利普·特里普·泰勒
415.937.5406
philip@gilmartinir.com
Source: Pulse Biosciences, Inc.
來源：Pulse Biosciences, Inc.
譯文內容由第三人軟體翻譯。